Tumor News and Research

RSS

New atraumatic uterine manipulator for minimally invasive gynecological surgery

Asociación RUVID Researchers from the Biomechanics and Ergonomics research group of the Universitat Jaume I, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) of the General University Hospital of Castelló and the Fisabio Foundation have developed an atraumatic uterine manipulator for minimally invasive gynaecological surgery.

15 Jun 2023

Breast cancer drug development work moves forward with support from STTR grant

Triple negative breast cancer is an aggressive subtype of breast cancer with worse survival outcomes than most.

14 Jun 2023

Using ultrasound for an effective sonodynamic treatment of orthotopic pancreatic cancer

Ultrasound is a promising technique for treating cancer. Unlike laser light, used in photodynamic cancer therapy, ultrasound waves can reach deep into tissue - up to 12 cm - to treat deep tumors without damaging healthy cells.

14 Jun 2023

Connecting the inflammatory dots: Obesity, depression, and Alzheimer's linked by neuroinflammation

Obesity-induced neuroinflammation significantly contributes to the pathophysiology of depression and Alzheimer's disease. Targeting midlife stage for intervention is crucial to potentially prevent Alzheimer's pathology.

13 Jun 2023

Maximizing the function and potential of stem cell-based treatments for patients with Type 1 diabetes

Following encouraging results from pre-clinical research and a recent clinical trial on stem cell-based treatments for patients with Type 1 diabetes, researchers are now working on maximizing the function and potential of stem cell-based treatments for future application in patients.

13 Jun 2023

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month after starting treatment, according to a recent study.

13 Jun 2023

Study provides a new and promising strategy for future cancer immunotherapies

CD8+ T cells, a vital component of the immune system that provides immunity against cancer, have been the focal point of anti-cancer therapies.

13 Jun 2023

Breaking barriers: hydrogel reservoir unleashes the potential of HSV-1 virotherapy in cancer

Researchers evaluated the therapeutic efficacy of Navoximod.

13 Jun 2023

Cracking the code: omega-3 and omega-6 fatty acids' impact on glucose metabolism

Researchers explored the impact of omega-3 and -6 fatty acids on glucose metabolism.

13 Jun 2023

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair."

13 Jun 2023

Manipulating white blood cells to eliminate solid tumors

By silencing the molecular pathway that prevents macrophages from attacking our own cells, Penn Engineers have manipulated these white blood cells to eliminate solid tumors.

12 Jun 2023

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin, a widely available oral medication, reduces SARS-CoV-2 viral load by 3.6-fold in outpatient trial, offering a potential treatment option. Ivermectin and fluvoxamine show no significant virologic effect.

12 Jun 2023

Researchers identify a potential breakthrough in glioblastoma treatment

In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment.

12 Jun 2023

Study raises new hopes for blood cancer patients with an incomplete response to CAR T cell therapy

The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T cell therapy is an immunotherapy that is effective in treating blood cancer.

12 Jun 2023

New material could usher in the next generation of cancer treatments

A new material, created at the little-explored intersection of organic and inorganic chemistry, could not only enable more powerful solar panels, but it could also usher in the next generation of cancer treatments.

12 Jun 2023

Study offers novel insights into the evolution of multiple myeloma

A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights into the evolution of multiple myeloma from precursor disease, which may help better identify patients likely to progress and develop new interventions.

12 Jun 2023

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Review discusses the increasing importance of two-dimensional nanomaterials like graphene in neuroscience, highlighting their potential in nerve repair, creating brain-mimicking synaptic devices, and treating neurological disorders. It also considers the challenges and future prospects of these materials in this complex field.

11 Jun 2023

Black, Hispanic breast cancer survivors have higher mortality risk after a second malignancy

Hispanic and non-Hispanic Black female survivors of breast cancer experience higher death rates after being diagnosed with a second primary cancer than members of other ethnic and racial groups, according to recent research from investigators at the Johns Hopkins Kimmel Cancer Center.

9 Jun 2023

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Researchers investigated the alveolar type II reparative response in COVID-19 pneumonia.

9 Jun 2023

Global trials could save lives by changing treatment procedure for cancer in the future

Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives by changing how we treat cancer in the near future.

9 Jun 2023

Tumor News and Research

New atraumatic uterine manipulator for minimally invasive gynecological surgery

Breast cancer drug development work moves forward with support from STTR grant

Using ultrasound for an effective sonodynamic treatment of orthotopic pancreatic cancer

Connecting the inflammatory dots: Obesity, depression, and Alzheimer's linked by neuroinflammation

Maximizing the function and potential of stem cell-based treatments for patients with Type 1 diabetes

Automated liquid biopsy test predicts early disease progression, survival among patients with metastatic breast cancer

Study provides a new and promising strategy for future cancer immunotherapies

Breaking barriers: hydrogel reservoir unleashes the potential of HSV-1 virotherapy in cancer

Cracking the code: omega-3 and omega-6 fatty acids' impact on glucose metabolism

Analyzing the role of LP-284 Hodgkin's lymphoma models and in DNA damage repair

Manipulating white blood cells to eliminate solid tumors

Metformin shows promising antiviral activity against SARS-CoV-2

Researchers identify a potential breakthrough in glioblastoma treatment

Study raises new hopes for blood cancer patients with an incomplete response to CAR T cell therapy

New material could usher in the next generation of cancer treatments

Study offers novel insights into the evolution of multiple myeloma

Revolution in neuroscience: 2D nanomaterials propel advances in brain repair, treatment, and diagnosis

Black, Hispanic breast cancer survivors have higher mortality risk after a second malignancy

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Global trials could save lives by changing treatment procedure for cancer in the future

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News